Depressive Disorders - South Africa

Revenue in the Depressive Disorders market is projected to reach US$119.70m in 2025.
Revenue is expected to show an annual growth rate (CAGR 2025-2029) of -0.12%, resulting in a market volume of US$119.15m by 2029.
In global comparison, most revenue will be generated United States (US$6.32bn in 2025).
In relation to total population figures, per person revenues of US$30.99 are generated in 2025.

Depressive disorders are a common type of mental illness. Symptoms include depressive moods such as feeling sad, low concentration, low self-worth, loss of interest in activities, and, in some cases, thoughts of suicide. Common treatments for depressive disorders include psychological treatments such as psychotherapy, behavioral therapy, and antidepressant medication.

The Depressive Disorders market in the Mental Health market represents the market for antidepressant drug sales. Different types of antidepressants are usually prescribed for the treatment of mild to serious cases of depression, e.g., selective serotonin reuptake inhibitors (SSRIs), serotonin norepinephrine reuptake inhibitor (SNRIs), serotonin modulators, as well as tricyclic and tetracyclic antidepressants.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Novartis AG, Pfizer, Bristol-Myers Squibb, GlaxoSmithKline, Patheon Inc, and Sandoz Inc.

Antidepressant drugs
Selective serotonin reuptake inhibitors (SSRIs)
Serotonin norepinephrine reuptake inhibitor (SNRIs)
Serotonin modulators
Tricyclic and tetracyclic antidepressants

Psychotherapy
Mood stabilizers
Anti-anxiety and stimulant medications
Behavioral therapy

Depressive Disorders: market data & analysis

The Depressive Disorders market in South Africa is experiencing significant growth and development, driven by various factors such as changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors.Customer preferences in the Depressive Disorders market in South Africa are shifting towards more accessible and affordable treatment options. Patients are increasingly seeking out alternative therapies, such as counseling and psychotherapy, in addition to traditional pharmaceutical treatments. This shift is driven by a growing awareness of the importance of mental health and a desire for holistic approaches to treatment. Additionally, patients are also seeking out personalized treatment plans that take into account their individual needs and preferences.Trends in the Depressive Disorders market in South Africa include the increasing use of technology and digital platforms for mental health support. Mobile applications and online platforms are becoming popular tools for accessing information, self-help resources, and connecting with mental health professionals. These digital solutions provide convenience and anonymity, making it easier for individuals to seek help and support for their depressive disorders. Furthermore, there is a growing focus on community-based initiatives and support networks, as individuals recognize the importance of social connections in managing their mental health.Local special circumstances in South Africa contribute to the development of the Depressive Disorders market. The country has a high prevalence of mental health disorders, including depressive disorders, which creates a significant demand for treatment and support services. The healthcare system in South Africa is also undergoing reforms to improve access to mental health services, which is further driving the growth of the market. Additionally, the country's diverse population and cultural beliefs influence the types of treatment options preferred by individuals, leading to a more varied and dynamic market.Underlying macroeconomic factors, such as economic growth and government investment in healthcare, also play a role in the development of the Depressive Disorders market in South Africa. As the economy grows, individuals have greater disposable income to spend on healthcare, including mental health treatment. The government's commitment to improving healthcare services, including mental health, through increased funding and policy reforms, further supports the growth of the market. These macroeconomic factors create an environment conducive to investment and innovation in the Depressive Disorders market.In conclusion, the Depressive Disorders market in South Africa is experiencing growth and development due to shifting customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. The market is evolving to meet the changing needs and preferences of individuals seeking treatment for depressive disorders, with a focus on accessibility, affordability, and personalized care. The use of technology and digital platforms, as well as community-based initiatives, are driving innovation in the market. Additionally, the prevalence of mental health disorders, government reforms, and economic growth contribute to the expansion of the market in South Africa.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.

Depressive Disorders - South Africa

Revenue

Patients

Analyst Opinion

Global Comparison

Methodology

Health

Access more Market Insights on Health topics with our featured report

Key Market Indicators

Explore more high-quality data on related topic

U.S. Mental Health Issues - Statistics & Facts

Contact